---
category: news
title: "Iktos and Sygnature Discovery announce a multi-year collaboration deal in AI for drug design"
excerpt: "Iktos, a company specialized in Artificial Intelligence (AI) for new drug design and Sygnature Discovery, a leading integrated drug discovery CRO headquartered in Nottingham, UK, with expertise across a range of therapeutic and biological target"
publishedDateTime: 2022-05-11T14:11:00Z
originalUrl: "https://www.pharmiweb.com/press-release/2022-05-11/iktos-and-sygnature-discovery-announce-a-multi-year-collaboration-deal-in-ai-for-drug-design"
webUrl: "https://www.pharmiweb.com/press-release/2022-05-11/iktos-and-sygnature-discovery-announce-a-multi-year-collaboration-deal-in-ai-for-drug-design"
type: article
quality: 26
heat: 26
published: false

provider:
  name: PharmiWeb
  domain: pharmiweb.com

topics:
  - AI

images:
  - url: "https://cdn.pharmiweb.com/media/1024/1200x448-pwjobs.png"
    width: 1200
    height: 448
    isCached: true

secured: "Uvfc8Ym+n2GdKfoKV6kiv9Yju12DO7UOK5DvecxF/sCZcKLmNkxFwuer95RtSgJzZbiSMtNz5lQAUKn0u30Cc6TXUwX0vJPPlfNnMd0XnOmDFN+6+DNGYyvDq+8yObODM671JJg8QcP4K+sC1CNje4t+kgh53v6kLlAbAp8ehkiQ0K5wGg9Dw58+dSRE/jseHKsW7uUPXr8tg7sA1qSNueDL9DLwZ7VKqC/bv0Pkta27CtIuUsEwLn8BSbwW9NsNPRG4KL8MB5NRDn+Fvqsp7kqlRd1w98BTGl0okCxA8FyuMdkP5wr2D0Fo3bjEGazTLLBoKWf8ZWUpo9cOfgbMVdQf5306KElue098+x96qCc=;67cdiqzCIMJIQlqLAWUI8w=="
---

